Harmony Biosciences (HRMY) IPO Opens 67% Higher

Today's IPO for Harmony Biosciences (NASDAQ: HRMY) opened for trading at $39.99 after pricing 5,348,837 shares of common stock at a price to the public of $24 per share.

In addition, Harmony has granted the underwriters a 30-day option to purchase up to an additional 802,325 shares of common stock at the initial public offering price, less underwriting discounts and commissions. All of the shares are being offered by Harmony.

Goldman Sachs & Co. LLC, Jefferies and Piper Sandler are acting as joint book-running managers for the offering.

Harmony Biosciences is a pharmaceutical company headquartered in Plymouth Meeting, PA and Chicago, IL. The company was established in October 2017 by Paragon Biosciences, LLC, with a vision to provide novel treatment options for people living with rare, neurological disorders who have unmet medical needs.

You May Also Be Interested In

• Viking Holdings (VIK) Announces 44M Share IPO at $21-$25/sh
• Serve Robotics (SERV) Opens At $4.75, IIPO At $4 (Earlier)
• Ibotta (IBTA) starts trading at $118, price IPO at $88